Dr. Mark A. Hoffman

Internal Medicine
BHMG United Medical
533 Lexington Ave, 
Clifton, NJ 
Accepting New Patients
Offers Telehealth
Before you request
BHMG United Medical
533 Lexington Ave, 
Clifton, NJ 

Overview

Mark Hoffman is a primary care provider, practicing in Internal Medicine in Clifton, New Jersey.

His clinical expertise encompasses Benign Rolandic Epilepsy, Type 2 Diabetes (T2D), Autosomal Dominant Partial Epilepsy with Auditory Features, and Vitamin D Deficiency.

He is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 3 clinical trials. Dr. Hoffman is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in NJ

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

BHMG United Medical
533 Lexington Ave, Clifton, NJ 07011

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire in Women With Breast or Gynecologic Cancer
Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire in Women With Breast or Gynecologic Cancer
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Drug
Study Drug: Bupropion Hydrochloride
Study Phase: Phase 2
A randoMized phAse II trIal of fulvestraNt wiTh or Without Ribociclib After Progression on AntI-estrogeN Therapy Plus Cyclin-dependent Kinase 4/6 Inhibition in Patients With Unresectable or Metastatic Hormone Receptor +, HER2 - Breast Cancer (MAINTAIN Trial)
A randoMized phAse II trIal of fulvestraNt wiTh or Without Ribociclib After Progression on AntI-estrogeN Therapy Plus Cyclin-dependent Kinase 4/6 Inhibition in Patients With Unresectable or Metastatic Hormone Receptor +, HER2 - Breast Cancer (MAINTAIN Trial)
Enrollment Status: Completed
Publish Date: December 06, 2024
Intervention Type: Drug
Study Drugs: LEE-011, Fulvestrant
Study Phase: Phase 2
A Phase II Study of Pembrolizumab Combined With Pegylated Liposomal Doxorubicin (PLD) For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer
A Phase II Study of Pembrolizumab Combined With Pegylated Liposomal Doxorubicin (PLD) For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer
Enrollment Status: Completed
Publish Date: September 13, 2022
Intervention Type: Drug
Study Drugs: Pembrolizumab, Pegylated Liposomal Doxorubicin
Study Phase: Phase 2
View 2 Less Clinical Trials

4 Total Publications

Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial.
Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial.
Journal: Gynecologic oncology
Published: June 10, 2020
Similar Doctors
Expertise in
39
conditions
Dr. Mark G. Lebwohl
Internal Medicine
Expertise in
39
conditions
Dr. Mark G. Lebwohl
Internal Medicine
Before you request

Icahn School Of Medicine At Mount Sinai

5 E 98th St, 
New York, NY 
 (11.3 miles away)
212-241-9728
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mark Lebwohl is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Lebwohl is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Plaque Psoriasis, Psoriasis, Pustular Psoriasis, and Generalized Pustular Psoriasis (GPP). Dr. Lebwohl is currently accepting new patients.

Expertise in
61
conditions
Dr. Marco Tartaglia
Internal Medicine
Expertise in
61
conditions
Dr. Marco Tartaglia
Internal Medicine

Orthopedic Specialist Group

20 Watsessing Ave, 
Bloomfield, NJ 
 (6.8 miles away)
973-364-0888
Languages Spoken:
English

Marco Tartaglia is a primary care provider, practicing in Internal Medicine in Bloomfield, New Jersey. Dr. Tartaglia is highly rated in 61 conditions, according to our data. His clinical expertise encompasses RASopathies, Noonan Syndrome, Rommen Mueller Sybert Syndrome, and Cardiomyopathic Lentiginosis.

Expertise in
14
conditions
Dr. John P. Bilezikian
Internal Medicine
Expertise in
14
conditions
Dr. John P. Bilezikian
Internal Medicine
Before you request

NewYork Presbyterian Columbia University Irving Medical Center

180 Fort Washington Ave, 
New York, NY 
 (10.5 miles away)
212-305-2663
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Bilezikian is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Bilezikian is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Hypoparathyroidism, Hypercalcemia, Milk-Alkali Syndrome, Parathyroidectomy, and Hormone Replacement Therapy (HRT). Dr. Bilezikian is currently accepting new patients.

Frequently Asked Questions about Dr. Mark A. Hoffman

How do I make an appointment with Dr. Mark A. Hoffman?

You can book an appointment with Dr. Mark A. Hoffman by calling their office at 973-437-5713. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark A. Hoffman a top-rated expert for Benign Rolandic Epilepsy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark A. Hoffman is classified as an Experienced expert for Benign Rolandic Epilepsy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark A. Hoffman specialize in?

While Dr. Mark A. Hoffman is a Internal Medicine, they have specific expertise in Benign Rolandic Epilepsy, Type 2 Diabetes (T2D), and Autosomal Dominant Partial Epilepsy with Auditory Features. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Mark A. Hoffman participate in research or clinical trials?

Yes. Dr. Mark A. Hoffman has published 4 articles and abstracts on conditions like Benign Rolandic Epilepsy. You can view a list of Dr. Mark A. Hoffman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark A. Hoffman accept my insurance?

Dr. Mark A. Hoffman accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 973-437-5713 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hoffman's expertise for a condition
ConditionClose
        View All 29 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile